The finding that PAR4 deletion resulted in smaller adipocytes is at odds with the effect of dabigatran, which increased WAT adipocyte size in Ldlr-/- mice with HFD-induced obesity (Feldmann et al. 2019). The gene discussed is LDLR; the disease is obesity due to melanocortin 4 receptor deficiency.